electroCore, Inc. (NASDAQ: ECOR) is a bioelectronic medicine company that develops and commercializes non-invasive vagus nerve stimulation therapy devices for medical and consumer wellness applications. Revenue comes from sales of prescription medical devices and direct-to-consumer wellness products, including the Truvaga app-enabled consumer product. The company competes in the neuromodulation device market against larger pharmaceutical and medical device companies, as well as dedicated neuromodulation competitors including Cefaly, Nerivo, and Savi Dual, all of which hold approvals for migraine treatment or prevention. electroCore is headquartered in Rockaway, New Jersey, where it maintains approximately 22,557 square feet of office, warehouse, and assembly space under a lease expiring July 31, 2034. The company has a history of significant losses and, as of the 10-K filed March 19, 2026, had not achieved sustained profitability or positive cash flow from operations.

Revenue model

Product sales of prescription neuromodulation devices and direct-to-consumer wellness products, including the Truvaga app-enabled consumer device. No subscription or royalty revenue structure is described in the filing excerpts.

Products and services

Non-invasive vagus nerve stimulation devices for medical indications including chronic pain and migraine treatment or prevention. Consumer wellness product: Truvaga, with a next-generation app-enabled version referenced as in development as of the filing date.

Customers and end markets

Patients and consumers in chronic pain and migraine end markets. Customers include physicians and direct-to-consumer buyers. The filing notes that some customers may treat products as discretionary purchases.

Value-chain role

Device developer, manufacturer, and direct commercializer. Operates assembly at its Rockaway, New Jersey facility and engages in direct-to-consumer sales as well as prescription channel sales. Uses social media platforms including Instagram, TikTok, Facebook, LinkedIn, and X for commercialization.

Geographic exposure

Primary operations in the United States, headquartered in Rockaway, New Jersey. The filing references operating in multiple countries but does not specify revenue by geography in the excerpts provided.

Competitors

Cefaly, Nerivo, Savi Dual

Source: SEC 10-K, filed 2026-03-19

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories Streamex Corp Sonendo, Inc. OMNIA WELLNESS INC. INVACARE HOLDINGS Corp NeuroOne Medical Technologies Corp Precision Optics Corporation Inc SANUWAVE Health Inc Vivani Medical Inc